Session – Small Scale Personalised Manufacturing – In-House & Outsourced Strategies & Challenges  Marc Wolfgang is the Vice President of Technical Operations at Neon Therapeutics, overseeing manufacture and quality control of neoantigen cancer vaccine and T-cell therapies. Marc has 25 years of biotech/pharma experience, holding various positions in CMC, quality and regulatory affairs at Cerulean Pharma, Momenta Pharmaceuticals, Millennium Pharmaceuticals, Biogen and Boehringer Ingelheim Pharmaceuticals. Marc has a B.S. degree in Biology and a M.S. degree in chemistry. He is the former Chairman of the Nanomedicines Alliance and a former steering committee member for AAPS’s Nanotechnology Focus Group.